SCHEMBL3843734

SCHEMBL3843734

CC(C)(C)OC(=O)NCCN[C@@H](Cc1nccn1COCC[Si](C)(C)C)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SUCNR1 Q9BXA5 11/20 0.37
ALDH1A1 P00352 1/20 0.36
GFER P55789 1/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
CKS1B P61024 1/20 0.34
SKP1 P63208 1/20 0.34
SKP2 Q13309 1/20 0.34
CYP1A1 P04798 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2B6 P20813 1/20 0.33
CYP2C19 P33261 1/20 0.33
CYP3A43 Q9HB55 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6749699 0.85 KDM4E (0.44) ALDH1A1GFERKDM4ELMNA
SCHEMBL4206991 0.78 KLKB1 (0.33)
SCHEMBL24509637 0.75 CYP17A1 (0.39)
SCHEMBL5546641 0.73 SUCNR1 (0.34) SUCNR1MEN1KMT2ANPSR1CKS1B
SCHEMBL8992439 0.72 ALDH1A1 (0.47) ALDH1A1GFERMEN1GAAKMT2A
SCHEMBL17282958 0.72 KDM4E (0.35) GAAKMT2AKDM4E
SCHEMBL6747810 0.72 FPR2 (0.37) KMT2ANPSR1
SCHEMBL18681721 0.71 FPR2 (0.37) GAAKMT2AKDM4ECYP2D6
SCHEMBL4203399 0.71 DGAT1 (0.33)
SCHEMBL3845409 0.70 MEN1 (0.42) ALDH1A1GFERMEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1311488-B1 SUBSTITUTED IMIDAZOLES AS TAFIA INHIBITORS PFIZER LTD (GB) 2009-11-04 EP disclosed
US-6949577-B2 Pharmaceuticals PFIZER, INC. (US) 2005-09-27 US disclosed
US-20030236420-A1 Pharmaceuticals ALLERTON CHARLOTTE MOIRA NORFO (GB) 2003-12-25 US disclosed
US-20020147229-A1 Pharmaceuticals PFIZER INC. 2002-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147229-A1 Pharmaceuticals BDKRB1, TFPI, BDKRB2 SUCNR1 3106/4885ALDH1A1 1013/4885GFER 2652/4885
US-20030236420-A1 Pharmaceuticals BDKRB1, TFPI, SERPINE1 SUCNR1 3110/4885ALDH1A1 1449/4885GFER 2831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.